Using the same expertise they’ve employed to build new organs for patients, scientists at Wake Forest Institute for Regenerative Medicine and colleagues have engineered micro hearts, lungs and livers that can potentially be used to test new drugs. By combining the micro-organs in a monitored system, the researchers aim to mimic how the human body responds to medications.
The goal of the effort, known as a “body-on-a-chip,” is to help reduce the estimated $2 billion price tag and 90 percent failure rate that pharmaceutical companies face when developing new medications. Drug compounds are currently screened in the lab using human cells and then tested in animals. But neither of these methods adequately replicates how drugs affect human organs.
“There is an urgent need for improved systems to accurately predict the effects of drugs, chemicals and biological agents on the human body,” said Anthony Atala, M.D., director of the institute and senior researcher on the multi-institution body on a chip project, funded by the Defense Threat Reduction Agency.
In Scientific Reports, published by Nature, the research team reports success engineering micro-sized 3D organs, known as organoids, and connecting them together on a single platform to monitor their function. While other teams have combined cells from multiple organs in a similar system, this is the first reported success using 3D organ structures, known to be higher functioning and to more accurately model the human body.
The organ structures were made from cell types found in native human tissue using 3D printing and other methods. Heart and livers were selected for the system because toxicity to these organs is a major reason for drug candidate failures and drug recalls. Lungs are the point of entry for toxic particles and also for aerosol drugs, such as asthma inhalers.
The organoids are placed in a sealed, monitored system – complete with real-time camera. A nutrient-filled liquid that circulates through the system keeps the organoids alive and is used to introduce potential drug therapies into the system.
The researchers first tested the organoids to ensure their similarity to human organs. For example, the micro-liver received a high dose of a common pain reliever – and then a different drug to counteract the toxic effects.
“The data show a significant toxic response to the drug as well as mitigation by the treatment, accurately reflecting the responses seen in human patients,” said Aleks Skardal, Ph.D., assistant professor at Wake Forest Institute for Regenerative Medicine, who represented the multi-investigator team as the lead author of the paper.
But more important than how an individual organ responds to drugs is how the body as a whole responds. In many cases during testing of new drug candidates – and sometimes even after the drugs have been approved for use – drugs have unexpected toxic effects in tissues not directly targeted by the drugs themselves.
“If you screen a drug in livers only, for example, you’re never going to see a potential side effect to other organs,” said Skardal. “By using a multi-tissue organ-on-a-chip system, you can hopefully identify toxic side effects early in the drug development process, which could save lives as well as millions of dollars.”
The scientists conducted multiple scenarios to ensure that the body-on-a- chip system mimics a multi-organ response. For example, they introduced a drug used to treat cancer into the system. Known to cause scarring of the lungs, the drug also unexpectedly affected the system’s heart. However, a control experiment using only the heart showed no response.
The scientists theorize that the drug caused inflammatory proteins from the lung to be circulated throughout the system. As a result, the heart increased beats and then later stopped altogether, indicating a toxic side effect.
“This was completely unexpected, but it’s the type of side effect that can be discovered with this system in the drug development pipeline,” Skardal said.
Scientists are working to increase the speed of the system for large scale screening, and also to add additional organs.
“Eventually we expect to demonstrate the utility of a body-on-a-chip system containing many of the key functional organs in the human body,” said Atala. “This system has the potential for advanced drug screening and also to be used in personalized medicine – to help predict an individual patient’s response to treatment.”
The Latest on: Body-on-a-chip
MIT researchers build device that may revolutionise drug testing
on March 17, 2018 at 2:22 am
The paperback-sized device, called a 'body-on-a-chip,' is capable of holding 10 artificial 'human' organs. Researchers have similarly created an 'organ-on-a-chip,' 'menstrual-cycle-on-a-chip' and a 'stem-cell-on-a-chip.' But unlike those devices ... […]
MIT scientists build 'body-on-a-chip' device that can store up to TEN artificial organs at once
on March 15, 2018 at 5:26 pm
Similarly, researchers have created an 'organ-on-a-chip,' 'menstrual-cycle-on-a-chip' and a 'stem-cell-on-a-chip.' But unlike those devices, MIT's microfluidic device is able to simulate how a drug might effect several key organs, rather than, say, just ... […]
"Body on a Chip" Tech Could Replace Animal Testing
on March 15, 2018 at 12:16 pm
In a major step forward for drug testing, scientists at MIT have invented a “body on a chip” that can host up to ten human “organs.” This “chip” includes patient-supplied tissue that can be grown into liver, lungs, guts, endometrium, brain ... […]
New 'Body-on-a-Chip' System Could Help Examine Effects of Drugs
on March 15, 2018 at 6:14 am
Engineers at the Massachusetts Institute of Technology (MIT) have recently developed what is called “body-on-a-chip” system to examine the effects of new drugs and detect possible side effects before the drugs are tested in humans. MIT engineers hope ... […]
Kalter: MIT team serves chips to advance biomed tests
on March 15, 2018 at 1:29 am
Researchers at the Massachusetts Institute of Technology have created a “body on a chip” that can test the effects of medications on the human body, which could someday do away with animal testing, scientists say. “What we’re trying to show is the ... […]
Body on a Chip to Study Drug Effects on Multiple Organ Systems Simultaneously
on March 14, 2018 at 12:11 pm
Researchers at MIT have developed an advanced microfluidic system that encompasses tissues from up to 10 organs. The device allows scientists to test the effects of drug candidates on multiple organ systems simultaneously. Screening drug candidates in this ... […]
Body on a chip could usher in a new generation of drug testing
on March 14, 2018 at 11:32 am
You may have heard of organs on a chip, but have you heard of a body on a chip? MIT researchers have developed a platform that connects engineered tissues from up to 10 organs, accurately replicating the interactions between these organs. Testing drugs is ... […]
A body-on-a-chip strings together 10 model human organs
on March 14, 2018 at 10:47 am
The new device could help researchers see how different types of tissue respond to drugs without using lab animals. Back story: Current organ-on-a chip systems place different kinds of human cells into a device andthen push fluid through them to mimic ... […]
'Body on a chip' could improve drug evaluation
on March 14, 2018 at 7:04 am
Engineers have developed new technology that could be used to evaluate new drugs and detect possible side effects before they are approved for human use. Using a microfluidic chip that connects tissue samples from up to 10 organs, the researchers can ... […]
'Body on a chip' may help drug evaluation by replicating multiple organs
on March 14, 2018 at 6:57 am
March 14 (UPI) --Computer technology -- known as a "body on a chip -- has been developed to evaluate new drugs and detect possible side effects on several organs before they are tested in humans, according to engineers at the Massachusetts Institute of ... […]
via Google News and Bing News